Stay updated on Pembrolizumab CNS Metastases Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.
Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedLocations section updated to include Massachusetts as a study location and the page revision updated to v3.3.3; the HHS Vulnerability Disclosure link was removed.SummaryDifference0.2%
- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedPubMed publications note updated to 'automatically filled in from PubMed' with an added revision tag (v3.3.2); the prior text describing PubMed publications (v3.2.0) was replaced. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check51 days agoChange DetectedDeleted a government funding/operating status notice that previously appeared on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check65 days agoChange DetectedNo additions or deletions were detected; the page content and layout appear unchanged.SummaryDifference0.4%
- Check94 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference3%
- Check101 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.